CAIP(SH:603035)2022-04-25 16:00Financial Performance - The company's operating revenue for Q1 2022 was RMB 682,169,934.28, representing a year-on-year increase of 12.21%[4] - The net profit attributable to shareholders decreased by 23.75% to RMB 78,670,156.22 compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses fell by 29.90% to RMB 64,475,046.19[4] - The basic earnings per share decreased by 26.67% to RMB 0.22, while diluted earnings per share decreased by 25.00% to RMB 0.21[4] - The net profit attributable to shareholders was 78.67 million RMB, a decrease of 23.75% year-on-year, primarily due to lower production from certain automotive clients affected by the pandemic and supply chain issues[18] - Net profit for Q1 2022 was ¥76.05 million, a decrease of 24.2% compared to ¥100.33 million in Q1 2021[30] - Total comprehensive income for Q1 2022 was ¥76.05 million, compared to ¥100.33 million in Q1 2021, indicating a decline of 24.2%[30] - Operating profit for Q1 2022 was ¥90.52 million, down from ¥113.16 million in Q1 2021, representing a decrease of 20.0%[28] - Net profit for the quarter was ¥29,207,473.79, down from ¥65,212,043.15, indicating a decline of approximately 55.2% year-over-year[44] - The company reported a total profit of ¥29,140,649.85, down from ¥65,141,806.10, reflecting a decrease of about 55.3%[44] Cash Flow and Liquidity - The net cash flow from operating activities increased significantly by 115.03% to RMB 171,442,748.14[4] - Cash and cash equivalents as of March 31, 2022, amounted to 572.17 million RMB, up from 442.56 million RMB at the end of 2021[19] - The net cash flow from investing activities was -42,823,902.94 RMB, compared to -56,190,112.63 RMB in the previous period, indicating an improvement[36] - The net cash flow from financing activities was -13,468,007.57 RMB, a significant decrease from -136,890,760.39 RMB year-over-year[36] - The company's cash and cash equivalents at the end of the period were 384,195,199.74 RMB, compared to 247,231,909.25 RMB at the end of the previous year, representing a substantial increase of 55.3%[36] - The net increase in cash and cash equivalents was 115,017,275.55 RMB, compared to a decrease of -111,544,258.59 RMB in the previous period, indicating a positive cash flow shift[36] - Cash flow from operating activities for Q1 2022 was ¥171.44 million, significantly higher than ¥79.73 million in Q1 2021[34] - Operating cash flow showed a significant outflow of ¥121,191,287.51 compared to an outflow of ¥39,626,473.75 in the previous year, reflecting a worsening cash flow situation[47] - Cash and cash equivalents at the end of the period increased to ¥295,961,499.31 from ¥139,499,315.94, a rise of about 112.5%[49] Assets and Liabilities - Total assets at the end of the reporting period were RMB 7,583,099,250.80, a slight increase of 0.9% from the end of the previous year[4] - Total assets reached 7.58 billion RMB, compared to 7.52 billion RMB at the end of 2021[23] - Total liabilities were 3.37 billion RMB, a slight decrease from 3.40 billion RMB at the end of 2021[26] - The total liabilities increased to 1,665,425,909.72 RMB from 1,557,564,990.18 RMB, representing an increase of approximately 6.9%[41] - The company's long-term equity investments decreased to 2,975,651,252.45 RMB from 3,019,585,369.97 RMB, a decline of about 1.5%[39] - Accounts receivable stood at 850.96 million RMB, down from 917.09 million RMB at the end of 2021[19] - Inventory decreased to 436.57 million RMB from 462.85 million RMB at the end of 2021[19] Shareholder Equity - Shareholders' equity attributable to the parent company increased by 2.52% to RMB 4,204,537,655.62 compared to the end of the previous year[4] - The company's total equity attributable to shareholders was 4.20 billion RMB, an increase from 4.10 billion RMB at the end of 2021[26] - The number of ordinary shareholders at the end of the reporting period was 28,560[11] Research and Development - The company experienced a 32.04% increase in R&D expenses due to hiring more personnel and optimizing production processes[11] - Research and development expenses increased to ¥25.13 million in Q1 2022, compared to ¥19.03 million in Q1 2021, reflecting a 32.2% rise[28] - R&D expenses increased to ¥3,043,330.41 from ¥2,815,517.09, representing a growth of approximately 8.1% year-over-year[44] Investment Income - Non-recurring gains and losses amounted to RMB 14,195,110.03, with government subsidies contributing RMB 11,020,451.61[8] - Investment income for Q1 2022 was ¥31.06 million, down 57.6% from ¥73.29 million in Q1 2021[28] - The company’s investment income decreased significantly to ¥31,064,382.48 from ¥73,285,160.43, a drop of approximately 57.6%[44]